Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs

被引：27

作者：

Bolten, WW ^{[1
]}

机构：

[1] Klaus Miehlke Klin, D-65191 Wiesbaden, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 01期

关键词：

D O I：

10.1136/ard.2005.036269

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treatment of pain in rheumatoid arthritis must take into account the gastrointestinal and cardiovascular risk of individual patients. Adequate results are not yet available, and until they are, treatment recommendations must take into account, not only the more favourable gastrointestinal risk profile of selective COX-2 inhibitors, but also the potential atherothrombotic risk of any NSAID or selective COX-2 inhibitor treatment.

引用

收藏

页码：7 / 13

页数：7

相关论文

共 44 条

[31] Platelet-active drugs - The relationships among dose, effectiveness, and side effects [J].

Patrono, C ;

Coller, B ;

Dalen, JE ;

FitzGerald, GA ;

Fuster, V ;

Gent, M ;

Hirsh, J ;

Roth, G .

CHEST, 2001, 119 (01) :39S-63S

[32]

PFIZER, 2005, BEXTRA VALDECOXIB TA

[33] Association between naproxen use and protection against acute myocardial infarction [J].

Rahme, E ;

Pilote, L ;

LeLorier, J .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) :1111-1115

[34] Cardiovascular toxicity of valdecoxib [J].

Ray, WA ;

Griffin, MR ;

Stein, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) :2767-2767

[35] Non-steroidal anti-inflamatory drugs and risk of serious coronary heart disease: an observational cohort study [J].

Ray, WA ;

Stein, CM ;

Hall, K ;

Daugherty, JR ;

Griffin, MR .

LANCET, 2002, 359 (9301) :118-123

[36] Mechanisms of disease - Atherosclerosis - An inflammatory disease [J].

Ross, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) :115-126

[37] Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial [J].

Schnitzer, TJ ;

Burmester, GR ;

Mysler, E ;

Hochberg, MC ;

Doherty, M ;

Ehrsam, E ;

Gitton, X ;

Krammer, G ;

Mellein, B ;

Matchaba, P ;

Gimona, A ;

Hawkey, CJ .

LANCET, 2004, 364 (9435) :665-674

[38] Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial [J].

Silverstein, FE ;

Faich, G ;

Goldstein, JL ;

Simon, LS ;

Pincus, T ;

Whelton, A ;

Makuch, R ;

Eisen, G ;

Agarwal, NM ;

Stenson, WF ;

Burr, AM ;

Zhao, WW ;

Kent, JD ;

Lefkowith, JB ;

Verburg, KM ;

Geis, GS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1247-1255

[39] Nonsteroidal anti-inflammatory drug use and acute myocardial infarction [J].

Solomon, DH ;

Glynn, RJ ;

Levin, R ;

Avorn, J .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) :1099-1104

[40] Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention [J].

Solomon, SD ;

McMurray, JJV ;

Pfeffer, MA ;

Wittes, J ;

Fowler, R ;

Finn, P ;

Anderson, WF ;

Zauber, A ;

Hawk, E ;

Bertagnolli, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1071-1080

← 1 2 3 4 5 →